Prognostic Value of Bronchoalveolar Lavage in Systemic Autoimmune Rheumatic Diseases-Associated Interstitial Lung Disease
Journal of Clinical Medicine · 22.06.2026 · 15 (12) · 4834
DOI: 10.3390/jcm15124834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.06.2026. Verfasst von Maximilian Robert Gysan und 25 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Systemic autoimmune rheumatic diseases-associated interstitial lung disease (SARD-ILD) presents with varied disease courses, emphasizing the need for reliable predictors of progression. The prognostic utility of bronchoalveolar lavage (BAL) in SARD-ILD remains underexplored. The objective of this study was to evaluate the role of BAL fluid lymphocyte count in predicting disease progression in patients with SARD-ILD.
Methods
This observational study included patients with SARD-ILD undergoing BAL as part of their diagnostic workup. Disease progression was defined as either Forced vital capacity (FVC) decrease >10%, two out of the following three criteria within two years: FVC decrease of 5–10%, worsening symptoms, increased fibrosis on imaging, or any of the following: escalation of treatment, Interstitial lung disease (ILD) exacerbation, lung transplantation, or disease-specific mortality. Logistic regression identified predictors of progression. Time-to-progression was assessed using Kaplan–Meier survival curves. The optimal BAL lymphocyte threshold for predicting progression was identified using the Youden Index and the Wilcoxon method.
Results
We identified 89 patients, of whom 30 (33.7%) had progressive disease. Progressors had a significantly higher BAL lymphocyte count compared to non-progressors (31.6 ± 24.8% vs. 14.3 ± 16.5%, p < 0.001). BAL lymphocyte proportion was significantly and independently associated with disease progression (odds ratio, 1.05; 95% confidence interval 1.02–1.07; p < 0.01). A lymphocyte count above 9 percent was associated with a markedly increased risk of disease progression (odds ratio, 13.14; 95% confidence interval, 4.20–51.98; p < 0.01).
Conclusions
BAL lymphocyte count was associated with a higher likelihood of progression in SARD-ILD. BAL assessment may help identify patients at increased risk of disease progression. However, these findings should be considered exploratory and require validation in larger prospective studies and across individual SARD-ILD subtypes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.
- Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Medicine II, Lower Austrian Centre for Rheumatology, Karl Landsteiner Institute for Clinical Rheumatology, State Hospital Stockerau, 2000 Stockerau, Austria.
ORCID-Profile: Maximilian Robert Gysan, Helmut Prosch, Christina Bal, Anastasia Papaporfyriou, Christopher Milacek, Karolina Anderle, Ahmed El-Gazzar, Helga Lechner-Radner
Zitieren
APA
Gysan, M. R., Kastrati, K., Pochepnia, S., Prosch, H., Lehmann, A., Lee, S., Renner, A., Bal, C., Papaporfyriou, A., Milacek, C., Antoniewicz, L., Metekol, S., Kramer, M., John, L., Kargarpour, Z., Aykara, I., Weber, P., Anderle, K., Kiener, H. P., …, & Lechner-Radner, H. (2026). Prognostic Value of Bronchoalveolar Lavage in Systemic Autoimmune Rheumatic Diseases-Associated Interstitial Lung Disease. Journal of Clinical Medicine, 15(12), 4834. https://doi.org/10.3390/jcm15124834
Vancouver
Gysan MR, Kastrati K, Pochepnia S, Prosch H, Lehmann A, Lee S, et al. Prognostic Value of Bronchoalveolar Lavage in Systemic Autoimmune Rheumatic Diseases-Associated Interstitial Lung Disease. Journal of Clinical Medicine. 2026;15(12):4834. doi:10.3390/jcm15124834
BibTeX
@article{Gysan2026,
author = {Gysan, Maximilian Robert and Kastrati, Kastriot and Pochepnia, Svitlana and Prosch, Helmut and Lehmann, Antje and Lee, Silvia and Renner, Andreas and Bal, Christina and Papaporfyriou, Anastasia and Milacek, Christopher and Antoniewicz, Lukasz and Metekol, Seda and Kramer, Markus and John, Lisa and Kargarpour, Zahra and Aykara, Iris and Weber, Peter and Anderle, Karolina and Kiener, Hans Peter and Bonelli, Michael and Mrak, Daniel and Aletaha, Daniel and El-Gazzar, Ahmed and Gompelmann, Daniela and Idzko, Marco and Lechner-Radner, Helga},
title = {Prognostic Value of Bronchoalveolar Lavage in Systemic Autoimmune Rheumatic Diseases-Associated Interstitial Lung Disease},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4834},
doi = {10.3390/jcm15124834}
}
EUVIMED